SecBot SecBot

NNVC

NANOVIRICIDES, INC.
NYSE· Pharmaceutical Preparations· Inc. DE· CIK 0001379006 Biotech & Drug Discovery
$1.40 +0.01 (+0.72%)
Oct 23 4:00 PM ET · prev $1.39
Market cap
$35.5M
Nano cap
Median target
🔒 Subscribers only
1 year
−8.5%
from $1.53 · Oct 24
30 days
−2.8%
from $1.44
52-week range
$0.8500–2.03
−31% from high · low Feb 5
Avg volume 20D
313.3K
Sep 29 spike 968.2K
Short interest
925.5K
≈3.6% of shares · +57.5%
Days to cover
1.1
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL NanoViricides filed Amendment No. 2 to its ATM prospectus supplement, updating the maximum remaining…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 4 added (0 new), 2 trimmed or exited.

  • Short sellersBUILDING

    Short interest +57.5% to 925.5K shares. 1.1 days to cover, ≈3.6% of shares.

  • TrendUPTREND

    7% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD919,313$1.3M
VANGUARD FIDUCIARY TRUST COADD131,923$182.1K
UBS Group AGTRIM99,331$137.1K
SUSQUEHANNA INTERNATIONAL GROUP, LLPTRIM60,616$83.7K
NORTHERN TRUST CORPDOUBLED51,265$70.7K
FMR LLCDOUBLED1,536$2.1K
GEODE CAPITAL MANAGEMENT, LLCADD225,381$205.6K
UBS Group AGDOUBLED213,359$194.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Jul 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Jul 6, 2026Noble Capital Markets
INITIATE
INITIATEOutperform

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 28, 2026
Earnings result
NNVC Q4 2026 Earnings: EPS $-0.1 (+2.0% vs est)
May 13, 2026
Earnings date
NNVC Q3 2026 Earnings Scheduled — 2026-05-13

Short side

FINRA· Sep 30, 2026
925,462
shares short
+57.5%
vs prior settlement
1.1
days to cover
≈3.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 21, 2026 SEC
NanoViricides filed Amendment No. 2 to its ATM prospectus supplement, updating the maximum remaining offering amount…
424B5 — Impact 3/10
Oct 8, 2026 SEC
NanoViricides filed its definitive proxy statement for the 2026 Annual Meeting, seeking re-election of three directors…
DEF 14A — Impact 3/10
Sep 28, 2026 Earnings result
NNVC Q4 2026 Earnings: EPS $-0.1 (+2.0% vs est)
Jul 27, 2026 SEC
NanoViricides is raising approximately $3.5M in net proceeds via a registered direct offering of 2,416,339 shares of…
424B5 — Impact 6/10
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
919,313 shares ($1.3M)
Jun 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO — ADD
131,923 shares ($182.1K)

SecBot reports

9 filings · 0 bullish · 4 bearish · 5 neutral
All NNVC filing & press-release reports (9)